Perrigo posts slight advance
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Perrigo reported group sales up by 1.9% to US$1.22 billion (€1.04 billion) in the first quarter of 2017, as turnover improved at both its consumer healthcare segments.